Clinical trial

Idebenone Treatment of Early Parkinson's Diseasesymptoms

NCT03727295

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Idebenone/placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Idebenone Treatment of Early Parkinson's Diseasesymptoms

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-01-01

PhasePHASE4

Conditions

Oxidative Stress is an Important Cause of Parkinson's Diseaseunresolved

Interventions

Idebenone/placeboDRUG

Sponsors & collaborators

Second Affiliated Hospital of Soochow Universitylead sponsor

Qilu Pharmaceutical Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03727295 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.